https://www.selleckchem.com/PARP.html
nti-cholesterol and antioxidant potentialities. Lung cancer is the leading cause of cancer-related deaths worldwide. Lung adenocarcinoma (LUAD) is one of the main subtypes of lung cancer. Hundreds of metabolic genes are altered consistently in LUAD; however, their prognostic role remains to be explored. This study aimed to establish a molecular signature that can predict the prognosis in patients with LUAD based on metabolic gene expression. The transcriptome expression profiles and corresponding clinical information of LUAD were obtained from The
Like
Comment
Share
